-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
"Pharmaceutical Network Industry Dynamics" Recently, the Fujian Provincial Drug Administration announced a typical case of punishment: a pharmaceutical company for the sale of melonbad drugs were fined 1.11 million.
the reason why this case is typical, mainly based on two backgrounds: First, this is the State Drug Administration to carry out a major overhaul of Chinese medicine tablets after the investigation.
in accordance with the requirements, from July 2020 to June 2021, the whole country to carry out a one-year centralized inspection of Chinese medicine tablets;
it is not difficult to see that the pharmaceutical industry has sounded the alarm! Drug regulation has become more stringent, drug companies are very high cost of illegal.
, in accordance with the provisions of the new version of the Drug Administration Law, the lower limit of the sale of counterfeit drugs is 1.5 million, and the retail inferior drugs lower limit is fined 100,000.
in accordance with the relevant provisions, the scope of counterfeit medicines include: the contents of drugs and the national standards of drugs do not conform to the provisions of the drug, the use of non-drugs or other drugs posing as such drugs, the deterioration of drugs, drugs marked by the indications or functional treatment beyond the prescribed scope. The scope of
inferior drugs includes: the content of pharmaceutical ingredients that do not meet the national drug standards, the contaminated drugs, the drugs that do not indicate or change the validity period, the drugs that do not indicate or change the product batch number, the drugs that exceed the validity period, the drugs that add preservatives and accessories without authorization, and other drugs that do not meet the drug standards.
in recent years, the regulation of The Chinese medicine tablet industry has become more stringent.
in accordance with the State Drug Administration this year issued the "Special Work Programme on the Special Treatment of Chinese Medicine Drink Tablets", Chinese medicine tablets and preparations production enterprises, Chinese medicine tablets operating use units, etc. are within the scope of inspection.
the latter focuses on the illegal production and operation of Chinese medicine tablets and the purchase of Chinese medicine tablets from illegal channels.
specific point of view, for the illegal production and operation of Chinese medicine drink tablets behavior.
check whether there is a situation for the sale of illegally processed and illegally distributed Chinese medicine tablets, whether there is a situation where a "out-of-bank" storage of Chinese medicine drink tablets or hanging on to operate Chinese medicine tablets, and whether it is a place, qualification certificate, bills and other conditions for illegal operation of Chinese medicine tablets by others.
targeting the purchase of Chinese medicine tablets from illegal sources.
check whether there is a situation of purchase of Chinese medicine drink tablets from no corresponding qualification unit, check whether to obtain the corresponding qualification certificate, legal bills (including sales list, with goods peer list, etc.) and the corresponding batch of product inspection report, check whether the procurement, acceptance, storage, maintenance, inventory review and other aspects of Chinese medicine drink tablets as required to effectively manage, and do a good job of recording.
this year, many provinces and cities have also introduced a focus on the inspection of Chinese medicine tablets regulatory measures.
for example, in April this year, the City Supervision Bureau of Jiujiang City, Jiangxi Province, issued the "Special Implementation Plan for the Special Treatment of Chinese Medicine Tablets in Jiujiang City", put forward the combination of special rectification of Chinese medicine tablets, focusing on the inspection of individual clinics, to achieve 100% inspection coverage.
public exposure of illegal and illegal activities and related enterprises, the natural persons who have been subject to qualification penalties in accordance with the law into the "black list" and the implementation of joint disciplinary measures;
with the country's comprehensive start to check Chinese medicine tablets, many pharmacies for the sale of fake drink tablets were punished.
For example, on August 3rd, the Guangdong Provincial Drug Administration announced that a chain of pharmacies had been fined 10,896.11 yuan for selling counterfeit drugs.
unique, Shandong recently also investigated two pharmacies, due to the sale of fake compound licorice tablets, two pharmacies were fined 5000 yuan.
in general, the "big check" affecting the pharmaceutical industry has been quietly opened.
not just Chinese medicine tablets, other drugs supervision and spot checks have also been carried out.
.